New York, NY 18 Nov 2021: The global maggot debridement market size is expected to reach USD 19.7 million by 2027 according to a new study by Polaris Market Research. The report “Maggot debridement Market Share, Size, Trends, Industry Analysis Report, By Administration Type (Biobags, Loose Larva); By End Use (Hospital, Wound Care Centers, Clinics & Others); By Application; By Regions; Segment Forecast, 2020-2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Maggot debridement therapy is defined as the future technology of the wound debridement process. Researchers are constantly developing different techniques for safe, quick, and easy wound debridement therapies. Maggot therapy helps in the treatment of pressure ulcers, neuropathic foot ulcers, non-healing dead skin & soft tissue wounds, venous stasis ulcers, and post-surgical wounds.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/maggot-debridement-market/request-for-sample
Recent developments in maggot debridement include the usage of sterile maggots in wound debridement therapy (MDT) in South Africa, the U.S., and Europe. The recent emergence of antimicrobial resistance has updated an interest in maggot debridement therapy utilizing the larvae of lucilia sericata and for this purpose, the Inqaba Biotec and the University of Pretoria have partnered together to expand the commercial production and for the usage of sterile maggots for wound healing in South Africa.
The significant factors favoring the global market growth include the increasing incidents of street mishaps, surgeries, burns, trauma, and road accidents globally that are responsible for the prolonged hospitalization due to the injuries & surgeries which drive the demand for these products. Every year around 2 million people are critically injured in accidents which have led to increased demand, propelling the market growth.
Companies such as Smith & Nephew, Monarch Labs, Coloplast, Mega Pharma (Pvt) Ltd., BioMonde, B. Braun Melsungen AG, Molnlycke Healthcare, ConvaTec, Lohmann & Rauscher, Arobella Medical, LLC Integra Lifesciences, Advancis Medical, DeRoyal Industries, RLS Global, EZ Debride & Sanara MedTech Inc. are some of the key players operating in the global market.
To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/maggot-debridement-market/request-for-discount-pricing
In April 2019, The RLS Global AB has announced that ChloraSolv, a wound care product, used for treating diabetic foot ulcers, has obtained a CE approval on the basis of the confirmation from Lloyd’s Register, (The Notified Body) & henceforth it is approved in 32 European countries for distribution. ChloraSolv is a Sweden based novel technology that utilizes RLS Global proprietary buffered hypochlorite technology for the debridement and cleaning of the wounds to assists in the natural wound healing process.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Polaris Market Research
Email: [email protected]